Suraksha Diagnostic Limited has formally intimated the BSE Limited and The National Stock Exchange of India Limited about an upcoming meeting of its Board of Directors.
The Board meeting is scheduled to be held on Tuesday, 10th November 2026, at the company's registered office located at 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India.
The primary agenda of the meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended 30th September 2026.
The company references its previous intimation letter dated Monday, 28th September 2026 regarding the closure of the trading window for this purpose. In accordance with the Company's Internal Code of Conduct for Prohibition of Insider Trading, framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window was closed from Thursday, 1st October 2026 for all directors, Key Managerial Personnel (KMPs), designated persons, employees, connected persons and their immediate relatives.
The trading window will re-open after the expiry of 48 hours from the date of declaration of the Financial Results.
This information is also available on the company's website at www.surakshanet.com.
The disclosure is signed by Shreya Arora, Company Secretary & Compliance Officer (Membership No.: ACS No. 30892) on behalf of Suraksha Diagnostic Limited (CIN: L85110WB2005PLC102265).
Company contact details: E-mail: investors@surakshanet.com, Phone: (033) 6605 9750.